Abstract
We present a case of advanced well-differentiated liposarcoma transforming to dedifferentiated liposarcoma in the bone marrow.Our patient presented with 5 weeks of worsening flank pain. He was found to have profound leukocytosis, thrombocytopenia, and normocytic anemia. Imaging showed a dominant retrocaval mass concerning for viable disease. Bone marrow biopsy revealed dedifferentiated liposarcoma with heterologous rhabdomyosarcomatous differentiation. He underwent 3 cycles of eribulin and subsequently developed complications of his increasingly aggressive liposarcoma. He was transitioned to hospice care and died 3 months after initial bone marrow biopsy. While exceedingly rare, it is possible for liposarcoma to metastasize to the bone marrow and cause rapid progression to death. In patients with high-grade liposarcoma, new cytopenia, leukocytosis, elevated granulocyte colony stimulating factor, and/or leukoerythroblasosis on peripheral smear should prompt bone marrow biopsy for early detection of this rare disease entity.
Reference15 articles.
1. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2. Key statistics for soft tissue sarcomas American Cancer Society . American Cancer society. 2023. Available: https://www.cancer.org/cancer/types/soft-tissue-sarcoma/about/key-statistics.html#:~:text=The%20American%20Cancer%20Society’s%20estimates,die%20of%20soft%20tissue%20sarcomas
3. UK CR . Soft tissue sarcoma Statistics. n.d. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/soft-tissue-sarcoma
4. Palbociclib-induced thrombotic microangiopathy in metastatic breast cancer patient surviving for 18 years;Raiss;Clinical Breast Cancer,2018
5. Leukoerythroblastosis in the Adult